Evidence-Based Use of Bevacizumab in the Management of Neovascular Age-Related Macular Degeneration | Ophthalmic Surgery, Lasers and Imaging Retina
Indicated for colorectal cancer for decades, bevacizumab has been widely used off label to treat retinal diseases, and the benefits of its use, specifically in neovascular age-related macular degeneration, have been demonstrated in multiple clinical …